It is currently considered that the treatment of psoriasis induced by TNF-α-antagonist should be assessed from the severity of psoriasis, the extent and degree of lesions, the impact on patients’ quality of life, and the effect on patients’ psychology, etc. Whether to use TNF-α-antagonist refers to a vital problem for treating psoriasis. Here, TNF is linked to psoriasis.